Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP714516.RAYuOnSAb0mWVAdiEiFDCkGTiPcHz-FlvukUBEvuWGlg4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP714516.RAYuOnSAb0mWVAdiEiFDCkGTiPcHz-FlvukUBEvuWGlg4130_assertion type Assertion NP714516.RAYuOnSAb0mWVAdiEiFDCkGTiPcHz-FlvukUBEvuWGlg4130_head.
- NP714516.RAYuOnSAb0mWVAdiEiFDCkGTiPcHz-FlvukUBEvuWGlg4130_assertion description "[A prospective study (average follow-up, 37 months) was conducted for major cardiovascular events (myocardial infarction [MI], stroke, cardiovascular death) from the Gargano Heart Study (GHS; n = 330 with type 2 diabetes and coronary artery disease), the Tor Vergata Atherosclerosis Study (TVAS; n = 141 who had MI), and the Cardiovascular Risk Extended Evaluation in Dialysis (CREED) database (n = 266 with end-stage renal disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714516.RAYuOnSAb0mWVAdiEiFDCkGTiPcHz-FlvukUBEvuWGlg4130_provenance.
- NP714516.RAYuOnSAb0mWVAdiEiFDCkGTiPcHz-FlvukUBEvuWGlg4130_assertion evidence source_evidence_literature NP714516.RAYuOnSAb0mWVAdiEiFDCkGTiPcHz-FlvukUBEvuWGlg4130_provenance.
- NP714516.RAYuOnSAb0mWVAdiEiFDCkGTiPcHz-FlvukUBEvuWGlg4130_assertion SIO_000772 21282363 NP714516.RAYuOnSAb0mWVAdiEiFDCkGTiPcHz-FlvukUBEvuWGlg4130_provenance.
- NP714516.RAYuOnSAb0mWVAdiEiFDCkGTiPcHz-FlvukUBEvuWGlg4130_assertion wasDerivedFrom befree-20140225 NP714516.RAYuOnSAb0mWVAdiEiFDCkGTiPcHz-FlvukUBEvuWGlg4130_provenance.
- NP714516.RAYuOnSAb0mWVAdiEiFDCkGTiPcHz-FlvukUBEvuWGlg4130_assertion wasGeneratedBy ECO_0000203 NP714516.RAYuOnSAb0mWVAdiEiFDCkGTiPcHz-FlvukUBEvuWGlg4130_provenance.